Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

[Evaluation of the benefit of different complementary exams in the search for a TB diagnosis algorithm for HIV patients put on ART in Niamey, Niger].

Ouedraogo E, Lurton G, Mohamadou S, Dillé I, Diallo I, Mamadou S, Adehossi E, Hanki Y, Tchousso O, Arzika M, Gazeré O, Amadou F, Illo N, Abdourahmane Y, Idé M, Alhousseini Z, Lamontagne F, Deze C, D'Ortenzio E, Diallo S.

Bull Soc Pathol Exot. 2016 Dec;109(5):368-375. doi: 10.1007/s13149-016-0532-z. French.

PMID:
27848101
2.

How to perform the skull vibration-induced nystagmus test (SVINT).

Dumas G, Perrin P, Ouedraogo E, Schmerber S.

Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Nov;133(5):343-348. doi: 10.1016/j.anorl.2016.04.002.

PMID:
27161530
3.

Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.

Dahourou DL, Amorissani-Folquet M, Coulibaly M, Avit-Edi D, Meda N, Timite-Konan M, Arendt V, Ye D, Amani-Bosse C, Salamon R, Lepage P, Leroy V; Monod Anrs 12206 Study Group..

J Int AIDS Soc. 2016 Mar 23;19(1):20601. doi: 10.7448/IAS.19.1.20601.

4.

Contribution of optical coherence tomography imaging in management of iatrogenic coronary dissection.

Barber-Chamoux N, Souteyrand G, Combaret N, Ouedraogo E, Lusson JR, Motreff P.

Cardiovasc Revasc Med. 2016 Mar;17(2):138-42. doi: 10.1016/j.carrev.2016.01.009.

PMID:
26994747
5.

Topographic analysis of the skull vibration-induced nystagmus test with piezoelectric accelerometers and force sensors.

Dumas G, Lion A, Perrin P, Ouedraogo E, Schmerber S.

Neuroreport. 2016 Mar 23;27(5):318-22. doi: 10.1097/WNR.0000000000000539.

PMID:
26872099
6.

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso.

Coulibaly M, Meda N, Yonaba C, Ouedraogo S, Congo M, Barry M, Thio E, Siribié I, Koueta F, Ye D, Kam L, Blanche S, Van De Perre P, Leroy V; MONOD Study Group ANRS 12206..

PLoS One. 2014 Oct 31;9(10):e111240. doi: 10.1371/journal.pone.0111240.

7.

Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.

Tiono AB, Kangoye DT, Rehman AM, Kargougou DG, Kaboré Y, Diarra A, Ouedraogo E, Nébié I, Ouédraogo A, Okech B, Milligan P, Sirima SB.

PLoS One. 2014 Jan 24;9(1):e86936. doi: 10.1371/journal.pone.0086936.

8.

A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB.

PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679.

9.

Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.

Renner LA, Dicko F, Kouéta F, Malateste K, Gueye RD, Aka E, Eboua TK, Azondékon A, Okomo U, Touré P, Ekouévi D, Leroy V; IeDEA West Africa Paediatric Collaboration..

J Int AIDS Soc. 2013 Sep 17;16:18024. doi: 10.7448/IAS.16.1.18024.

10.

Use and teaching of pneumatic otoscopy in a family medicine residency program.

Ouedraogo E, Labrecque M, Côté L, Charbonneau K, Légaré F.

Can Fam Physician. 2013 Sep;59(9):972-9.

11.

Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies.

Gansane A, Ouedraogo IN, Henry NB, Soulama I, Ouedraogo E, Yaro JB, Diarra A, Benjamin S, Konate AT, Tiono A, Sirima SB.

Mem Inst Oswaldo Cruz. 2013 Aug;108(5):644-50.

12.

Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.

Ouédraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, Ouedraogo E, Bougouma EC, Soulama I, Gansané A, Ouedraogo A, Konate AT, Nebie I, Watson NL, Sanza M, Dube TJ, Sirima SB.

PLoS One. 2013;8(1):e50036. doi: 10.1371/journal.pone.0050036.

13.

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso.

Diarra A, Nébié I, Tiono A, Sanon S, Soulama I, Ouédraogo A, Gansané A, Yaro JB, Ouédraogo E, Traoré AS, Sirima SB.

Parasit Vectors. 2012 May 30;5:103. doi: 10.1186/1756-3305-5-103.

14.

Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso.

Bougouma EC, Tiono AB, Ouédraogo A, Soulama I, Diarra A, Yaro JB, Ouédraogo E, Sanon S, Konaté AT, Nébié I, Watson NL, Sanza M, Dube TJ, Sirima SB.

Malar J. 2012 May 4;11:154. doi: 10.1186/1475-2875-11-154.

15.

Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso.

Sanou GS, Tiendrebeogo RW, Ouédraogo AL, Diarra A, Ouédraogo A, Yaro JB, Ouédraogo E, Verra F, Behr C, Troye-Blomberg M, Modiano D, Dolo A, Torcia MG, Traoré Y, Sirima SB, Nébié I.

BMC Res Notes. 2012 Jan 27;5:76. doi: 10.1186/1756-0500-5-76.

16.

Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.

Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood BM, Diallo DA.

PLoS One. 2011;6(8):e23391. doi: 10.1371/journal.pone.0023391.

17.

Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.

Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood B, Diallo DA.

PLoS Med. 2011 Feb 1;8(2):e1000408. doi: 10.1371/journal.pmed.1000408.

18.

[Epidemio-clinical aspects of adult acute bacterial pneumonia at Yalgado Ouédraogo University Health Center].

Ouédraogo SM, Toloba Y, Badoum G, Ouédraogo G, Boncoungou K, Bambara M, Ouédraogo EW, Zigani A, Sangaré L, Ouédraogo M.

Mali Med. 2010;25(3):15-8. French.

PMID:
21441088
19.

[Epidemio-clinical aspects of bacterial acute infant Pneumopathies at Yalgado Ouédraogo University Health Center].

Ouédraogo SM, Toloba Y, Ouédraogo G, Badoum G, Boncoungou K, Bambara M, Ouédraogo EW, Zigani A, Sangaré L, Ouédraogo M, Kam L.

Mali Med. 2010;25(3):19-22. French.

PMID:
21441087
20.

Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.

Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma EC, Konaté AT, Kaboré Y, Traoré A, Chilengi R, Soulama I, Luty AJ, Druilhe P, Cousens S, Nébié I.

PLoS One. 2009 Oct 26;4(10):e7549. doi: 10.1371/journal.pone.0007549. Erratum in: PLoS One. 2010;5(4). doi: 10.1371/annotation/3221b8d9-038d-4e67-82fa-de6b1233b459. Druilhe, Pierre [added]; Roma, Chilengi [corrected to Chilengi, Roma].

Items per page

Supplemental Content

Loading ...
Support Center